The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
Mesenchymal Stem Cell: Keystone of the Hematopoietic Stem Cell Niche and a Stepping-Stone for Regenerative Medicine
Open accessAbstract
Mesenchymal stem cells (MSCs) are self-renewing precursor cells that can differentiate into bone, fat, cartilage, and stromal cells of the bone marrow. Recent studies suggest that MSCs themselves are critical for forming a niche that maintains hematopoietic stem cells (HSCs). The ease by which human MSC-like and stromal progenitor cells can be isolated from the bone marrow and other tissues has led to the rapid development of clinical investigations exploring their anti-inflammatory properties, tissue preservation capabilities, and regenerative potential. However, the identity of genuine MSCs and their specific contributions to these various beneficial effects have remained enigmatic. In this article, we examine the definition of MSCs and discuss the importance of rigorously characterizing their stem cell activity. We review their role and that of other putative niche constituents in the regulation of bone marrow HSCs. Additionally, how MSCs and their stromal progeny alter immune function is discussed, as well as potential therapeutic implications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, reprogrammed immune cells can use the immune system to treat cancer and administer vaccinations, while microorganisms can interact with the microbiome to control metabolic processes, chronic inflammatory processes, and mucosal immunity.320–322”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [322]
In the citing paper
“For instance, reprogrammed immune cells can use the immune system to treat cancer and administer vaccinations, while microorganisms can interact with the microbiome to control metabolic processes, chronic inflammatory processes, and mucosal immunity.320–322”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [322]
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrow
Jiang, Y., Jahagirdar, B., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., Reyes, M., Lenvik, T. R., Lund, T. C., Blackstad, M., et al. (2002) · Nature · doi:10.1038/nature00870 · Cited by 5,523
RetractedMultilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Zuk, P. A., Zhu, M., Ashjian, P. H., Ugarte, D. A. D., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., & Hedrick, M. H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0105 · Cited by 6,762
Caplan, A. I. (1991) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100090504 · Cited by 6,559
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo
Gronthos, S., Mankani, M. H., Brahim, J. S., Robey, P. G., & Shi, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240309797 · Cited by 4,580
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
A Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow Cells1
Till, J. E., & McCulloch, E. A. (2010) · Radiation Research · doi:10.1667/rrxx28.1 · Cited by 4,036
A perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991
Research works printed but not linked: 10
- Friedenstein AJ, 1976, Exp. Hematol., 4, 267
- Friedenstein AJ, 1982, Exp. Hematol., 10, 217
- Dexter TM, 1977, Biomedicine, 27, 344
- Maltman DJ, 2011, Neurochem. Int., 59, 347
- in ‘t Anker PS, 2003, Haematologica, 88, 845
- Owen M, 1988, Ciba Found. Symp., 136, 42
- 10.1016/0008-6363(96)00063-6 · DOI
- Schofield R, 1978, Blood Cells, 4, 7
- Studeny M, 2002, Cancer Res., 62, 3603
- Cyranoski D, 2011, Nature, 477, 377
Cited by
Sorted by citations
Items 101–200 of 462
Metabolic Regulation of Hematopoietic Stem Cells
Morganti, C., Cabezas‐Wallscheid, N., & Ito, K. (2022) · HemaSphere · doi:10.1097/hs9.0000000000000740 · Cited by 82
Cosson, S., Otte, E. A., Hezaveh, H., & Cooper-White, J. J. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0203 · Cited by 68
Stromal cell-derived factor-1 (CXCL12) and its role in bone and muscle biology
Gilbert, W. B., Bragg, R., Elmansi, A. M., McGee‐Lawrence, M. E., Isales, C. M., Hamrick, M. W., Hill, W., & Fulzele, S. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154783 · Cited by 67
Transition of Mesothelial Cell to Fibroblast in Peritoneal Dialysis: EMT, Stem Cell or Bystander?
Liu, Y., Dong, Z., Liu, Z., Zhu, J., Liu, F., & Chen, G. (2015) · Peritoneal Dialysis International · doi:10.3747/pdi.2014.00188 · Cited by 67
“The rigorous definition of tissue progenitor cell or tissue stem cell remains lacking due to the differences among cell populations derived from various sources of tissues (129,130).”
BackgroundSwitch from Canonical to Noncanonical Wnt Signaling Mediates High Glucose-Induced Adipogenesis
Keats, E. C., Dominguez, J. M., Grant, M. B., & Khan, Z. A. (2014) · Stem Cells · doi:10.1002/stem.1659 · Cited by 66
Haematopoietic stem cell niches: new insights inspire new questions
Ugarte, F., & Forsberg, E. C. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.201 · Cited by 66
“Mapping the overlap and differentiation potential of different MSPC populations promise to be particularly productive, given their purported importance in HSC maintenance (Frenette et al , 2013).”
InfluentialSecretome analysis of human bone marrow derived mesenchymal stromal cells
Baberg, F., Geyh, S., Waldera-Lupa, D. M., Stefanski, A., Zilkens, C., Haas, R. R., Schroeder, T. A., & Stühler, K. (2019) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2019.01.013 · Cited by 65
Pleyer, L., Valent, P., & Greil, R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071009 · Cited by 63
“Several years ago it was speculated that all MSPCs may be pericytes [147]; however, this hypothesis seems unlikely, and the extent of functional and biological overlap between pericytes and MSPCs remains unclear at present (for review see [60]) (Figure 1B).”
BackgroundInfluentialHuang, H., Zhang, X., Hu, X., Dai, L., Zhu, J., Man, Z., Chen, H., Zhou, C., & Ao, Y. (2014) · Biomedical Materials · doi:10.1088/1748-6041/9/3/035008 · Cited by 59
“Recently, mesenchymal stem cells (MSCs) have been studied extensively for tissue engineering because of their convenient availability, high expansion capacity, lack of significant immunogenicity and multipotent differentiation capability [1, 33, 34].”
BackgroundLee, H., Kim, S., Shin, S., Jeong, S., Lee, D.-W., Lim, S.-U., Kang, J. Y., Son, M., Lee, C., Yu, K., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010881 · Cited by 59
“Accumulating studies have shown that the primary mode of action for MSCs is the paracrine support of tissue regeneration both by inhibiting apoptosis and fibrosis [4] and by stimulating the regeneration of endogenous stem cells such as hematopoietic stem cells (HSCs), neuronal stem cells, and other tissue-specific end…”
BackgroundOsteogenic Potential of Mesenchymal Stromal Cells Contributes to Primary Myelofibrosis
Martinaud, C., Desterke, C., Konopacki, J., Pieri, L., Torossian, F., Golub, R., Schmutz, S., Anginot, A., Guerton, B., Rochet, N., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3696 · Cited by 58
“MSCs also function as a repository for precursor cells participating in bone development, maintenance, and remodeling (6).”
BackgroundJin, G., Mao, D., Cai, P., Liu, R., Tomczak, N., Liu, J., Chen, X., Kong, D., Ding, D., Liu, B., et al. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201501081 · Cited by 58
Sarcoma Stem Cell Heterogeneity
Hatina, J., Kripnerová, M., Houfková, K., Pešta, M., Kuncová, J., Šáňa, J., Slabý, O., & Rodrı́guez, R. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-11096-3_7 · Cited by 58
Bhartiya, D., Singh, P., Sharma, D., & Kaushik, A. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10243-6 · Cited by 58
Naji, A., Rouas‐Freiss, N., Dürrbach, A., Carosella, E. D., Sensebé, L., & Deschaseaux, F. (2013) · Stem Cells · doi:10.1002/stem.1494 · Cited by 58
Minieri, V., Saviozzi, S., Gambarotta, G., Iacono, M. L., Accomasso, L., Rocchietti, E. C., Gallina, C., Turinetto, V., & Giachino, C. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12387 · Cited by 61
“The endogenous role for hMSCs is maintenance of stem cell niches (classically the haematopoietic), and as such, hMSCs participate in organ homeostasis, wound healing and successful ageing [2].”
BackgroundYuan, L., Jiang, J., Liu, X., Zhang, Y., Zhang, L., Xin, J., Wu, K., Li, X., Cao, J., Guo, X., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316091 · Cited by 59
Exploring mesenchymal stem cells homing mechanisms and improvement strategies
Sajjad, U., Ahmed, M. Z., Iqbal, M. Z., Riaz, M., Mustafa, M., Biedermann, T., & Klar, A. S. (2024) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szae045 · Cited by 57
“27 Therefore, the improvement of MSCs’ homing efficiency is necessary since delivering MSCs to the injury site represents the key feature of their therapeutic efficacy.”
Zanotti, L., Angioni, R., Calì, B., Soldani, C., Ploia, C., Moalli, F., Gargesha, M., D’Amico, G., Elliman, S. J., Tedeschi, G., et al. (2016) · Leukemia · doi:10.1038/leu.2016.33 · Cited by 57
Declining histone acetyltransferase GCN5 represses BMSC‐mediated angiogenesis during osteoporosis
Jing, H., Liao, L., Su, X., Shuai, Y., Zhang, X., Deng, Z., & Jin, Y. J. (2017) · The FASEB Journal · doi:10.1096/fj.201700118r · Cited by 55
“mote angiogenesis and tissue repair (10), indicating that BMSCs are strong candidates for regulation of angiogen-”
BackgroundMesenchymal Stem Cells Recruit CCR2+ Monocytes To Suppress Allergic Airway Inflammation
Takeda, K., Webb, T. L., Ning, F., Shiraishi, Y., Regan, D. P., Chow, L., Smith, M. J., Ashino, S., Guth, A., Hopkins, S., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700562 · Cited by 56
“disease, arthritis, allergic encephalitis, and respiratory diseases including asthma (4, 5, 7, 8).”
BackgroundLui, J. C. K., Yue, S., Lee, A., Kikani, B., Temnycky, A. G., Barnes, K. M., & Baron, J. (2019) · Bone · doi:10.1016/j.bone.2019.05.027 · Cited by 55
Ecological Balance of Oral Microbiota Is Required to Maintain Oral Mesenchymal Stem Cell Homeostasis
Su, Y., Chen, C., Guo, L., Du, J., Li, X., & Liu, Y. F. (2017) · Stem Cells · doi:10.1002/stem.2762 · Cited by 53
Xie, H. W., Sun, L., Zhang, L., Liu, T., Chen, L., Zhao, A., Lei, Q., Gao, F., Zou, P., Li, Q., et al. (2016) · Stem Cells International · doi:10.1155/2016/6493241 · Cited by 53
“Mesenchymal stem cells (MSCs) are adult stem cells of mesodermal origin that have been identified as one major component of the bone marrow hematopoietic microenvironment [5].”
Current progress of mesenchymal stem cell membrane-camouflaged nanoparticles for targeted therapy
Fan, L., Wei, A., Gao, Z., & Mu, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114451 · Cited by 57
Efficacy of ALK5 inhibition in myelofibrosis
Yue, L., Bartenstein, M., Zhao, W., Ho, W., Han, Y., Murdun, C., Mailloux, A. W., Zhang, L., Wang, X., Budhathoki, A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.90932 · Cited by 53
Influence of Bone Marrow Microenvironment on Leukemic Stem Cells
Agarwal, P., & Bhatia, R. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2015.04.007 · Cited by 51
Regulation of mesenchymal stromal cells through fine tuning of canonical Wnt signaling
Kim, J., Choi, H., Kim, T., Leem, S., & Oh, I. (2015) · Stem Cell Research · doi:10.1016/j.scr.2015.02.007 · Cited by 52
“for therapeutic trials, facilitating the establishment of a regenerative microenvironment for hematopoietic stem cells (HSCs), neuronal stem cells, and other tissue-specific stem cells (Frenette et al., 2013; Murphy et al., 2013; Satija et al., 2009).”
BackgroundYang, M., Arai, A., Udagawa, N., Hiraga, T., Zhao, L., Ito, S., Komori, T., Moriishi, T., Matsuo, K., Shimoda, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05401-1 · Cited by 50
This Niche Is a Maze; An Amazing Niche
Hanoun, M., & Frenette, P. S. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.03.012 · Cited by 49
“For example, prior studies have suggested that the endosteal region, populated by osteoblasts, was a niche maintaining quiescent HSCs, whereas other studies have suggested that most HSCs are found near blood vessels (reviewed in Mercier et al., 2012; Frenette et al., 2013).”
BackgroundResultSelf-citationGraphene Oxide: A Carrier for Pharmaceuticals and a Scaffold for Cell Interactions
Durán, N., Martinez, D. S. T., Silveira, C. P., Durán, M., de Moraes, A., Simoes, M., Alves, O. L., & Fávaro, W. J. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150108144217 · Cited by 49
Dissecting Tumor-Stromal Interactions in Breast Cancer Bone Metastasis
Kang, Y. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.2.206 · Cited by 47
Yokoyama, T., Nakatake, M., Kuwata, T., Couzinet, A., Goitsuka, R., Tsutsumi, S., Aburatani, H., Valk, P. J. M., Delwel, R., & Nakamura, T. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81516 · Cited by 46
Engineering a multicellular vascular niche to model hematopoietic cell trafficking
Kotha, S. S., Hayes, B. J., Phong, K. T., Redd, M. A., Bomsztyk, K., Ramakrishnan, A., Torok‐Storb, B., & Zheng, Y. Y. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0808-2 · Cited by 46
“derived MSCs has led to diverse outcomes due to inconsistent definition of the MSC cell type and varying coculture conditions [4, 48, 49].”
Yang, M., Arai, A., Udagawa, N., Zhao, L., Nishida, D., Murakami, K., Hiraga, T., Takao-Kawabata, R., Matsuo, K., Komori, T., et al. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3811 · Cited by 46
“previous study demonstrated that iPTH treatment increased the colony‐forming unit‐fibroblast (CFU‐F) number, which is indicative of self‐renewal capacity of stem cells, of BM cells in rats.((43,44))”
More than a scaffold: Stromal modulation of tumor immunity
Johansson, A., Hamzah, J., & Ganß, R. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.06.001 · Cited by 47
“In a pro-inflammatory cytokine milieu multiple factors released by mesenchymal stem cells are involved in immune suppression which includes PGE2, IL6, NO and the enzyme indoleamine 2,3-dioxygenase (IDO) [66].”
BackgroundMarian, D., Toro, G., D’Amico, G., Trotta, M. C., D’Amico, M., Petre, A. E., Lile, I. E., Hermenean, A. O., & Fratila, A. M. (2024) · Medicina · doi:10.3390/medicina61010020 · Cited by 45
Wang, M., Feng, R., Zhang, J., Xu, L.-L., Feng, F., Wang, C., Wang, Q., Zhu, X., He, Y., Xue, J., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018026690 · Cited by 45
“Nestin(1) MSCs are relatively rare nonhematopoietic perivascular cells that are innervated by SNs; they exhibit all colony-forming unit fibroblastic activities and are an essential cellular component of the BM niche.(15,18,45) As an important subset of MSCs and the major source of CXCL12 in the BM, nestin(1) MSCs are…”
BackgroundCellular senescence and hematological malignancies: From pathogenesis to therapeutics
Hu, D., Yuan, S., Zhong, J., Liu, Z., Wang, Y., Liu, L., Li, J., Wen, F., Liu, J., & Zhang, J. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107817 · Cited by 47
Exosome- and extracellular vesicle-based approaches for the treatment of lysosomal storage disorders
Lü, B., Ku, J., Flojo, R. A. B., Olson, C., Bengford, D., & Marriott, G. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114465 · Cited by 47
Mesenchymal Stem Cells Facilitate In Vitro Development of Human Preantral Follicle
Xia, X., Wang, T., Yin, T., Yan, L., Yan, J., Lu, C., Zhao, L., Li, M., Zhang, Y., Jin, H., et al. (2015) · Reproductive Sciences · doi:10.1177/1933719115578922 · Cited by 45
“Last but not least, compared to other types of stem cells such as embryonic stem cells and induced pluripotent stem cells, MSCs are considered out of ethical problems and legal concerns.(15,49) In recent years, bone marrow-derived MSCs were extensively studied in various clinical trials including regenerative medicine…”
BackgroundOptimization of the Platelet-Rich Plasma Concentration for Mesenchymal Stem Cell Applications
Wang, K., Li, Z., Li, J., Liao, W., Qin, Y., Zhang, N., Huo, X., Mao, N., & Zhu, H. (2018) · Tissue Engineering Part A · doi:10.1089/ten.tea.2018.0091 · Cited by 43
“13,14 In addition, MSCs are able to suppress immune cell development and function in a dose-dependent manner by means of secretory factors and/or direct contact.”
Brun, J., Lutz, K. A., Neumayer, K. M. H., Klein, G., Seeger, T., Uynuk‐Ool, T., Wörgötter, K., Schmid, S., Kraushaar, U., Guenther, E., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145153 · Cited by 42
“Human mesenchymal stromal cells (MSCs) are multipotent adult progenitor cells capable of differentiating into a variety of cell types and have regenerative potential [4,5].”
BackgroundCao, M., Chan, R., Cheng, F. H. C., Li, J., Li, T., Pang, R. T. K., Lee, C., Li, R., Ng, E. H. Y., Chiu, P. C. N., et al. (2019) · Stem Cells · doi:10.1002/stem.3070 · Cited by 42
Bhattacharya, S. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102194 · Cited by 42
Mesenchymal stem cell printing and process regulated cell properties
Snyder, J., Son, A. R., Hamid, Q., Wang, C., Lui, Y., & Sun, W. (2015) · Biofabrication · doi:10.1088/1758-5090/7/4/044106 · Cited by 42
Perucca, S., Palma, A. D., Piccaluga, P. P., Gemelli, C., Zoratti, E., Bassi, G., Giacopuzzi, E., Lojacono, A., Borsani, G., Tagliafico, E., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172430 · Cited by 41
Therapeutic Antibodies for Myeloid Neoplasms—Current Developments and Future Directions
Schürch, C. M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00152 · Cited by 42
Paz, J. L., Levy, D., Oliveira, B. A., de Melo, T. C., de Freitas, F. A., Reichert, C. O., Rodrigues, A., Pereira, J. C., & Bydlowski, S. P. (2019) · Cells · doi:10.3390/cells8050482 · Cited by 42
“MSCs contribute substantially to the creation of a hematopoietic niche [8,9]; they can secrete several cytokines/growth factors that can modulate the immune response and increase the potential for the expansion and differentiation of host cells [10].”
BackgroundMesenchymal stem cells to treat type 1 diabetes
Pixley, J. S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.033 · Cited by 39
Shift of EMT gradient in 3D spheroid MSCs for activation of mesenchymal niche function
Jeon, S., Lee, H., Lee, G., Park, G., Kim, T., Shin, J., Lee, C., & Oh, I. (2017) · Scientific Reports · doi:10.1038/s41598-017-07049-3 · Cited by 40
Cell lineage branching as a strategy for proliferative control
Buzi, G., Lander, A. D., & Khammash, M. (2015) · BMC Biology · doi:10.1186/s12915-015-0122-8 · Cited by 38
“Such choices create branches in cell lineages, and examples of such branching exist in both vertebrates and invertebrates, during development and regeneration, and in both solid and blood-borne tissues [21-25].”
BackgroundTherapeutic Implications of Newly Identified Stem Cell Populations from the Skin Dermis
Chen, Z., Wang, Y., & Shi, C. (2014) · Cell Transplantation · doi:10.3727/096368914x682431 · Cited by 39
Modeling Selective Elimination of Quiescent Cancer Cells from Bone Marrow
Cavnar, S. P., Rickelmann, A. D., Meguiar, K. F., Xiao, A., Dosch, J. S., Leung, B. M., Lesher‐Pérez, S. C., Chitta, S., Luker, K. E., Takayama, S., et al. (2015) · Neoplasia · doi:10.1016/j.neo.2015.08.001 · Cited by 38
“Breast cancer cells localize adjacent to MSC, potentially displacing hematopoietic stem cells from protective bone marrow niches formed by MSC [8,9].”
BackgroundA Chemoattractant-Guided Walk Through Lymphopoiesis
Lim, V., Zehentmeier, S., Fistonich, C., & Pereira, J. P. (2017) · Advances in immunology · doi:10.1016/bs.ai.2017.02.001 · Cited by 40
Li, X., Li, C., Tang, Y., Huang, Y., Cheng, Q., Huang, X., Zhao, F., Hao, C., Feng, D., Xu, J., et al. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00002.2018 · Cited by 38
“BM acts as a repository for various stem cell populations, which are mobilized at varying degrees into the peripheral circulation after damage (17).”
Sinha, S., Biswas, M., Chatterjee, S. S., Kumar, S., & Sengupta, A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107570 · Cited by 38
Yuan, Y., Tan, S., Wang, H., Zhu, J., Li, J., Zhang, P., Wang, M., & Zhang, F. (2023) · Analytical Cellular Pathology · doi:10.1155/2023/4024887 · Cited by 38
“Evidence has manifested that the function of MSCs from AML patients has changed [8, 9].”
BackgroundFostering mesenchymal stem cell therapy to halt cytokine storm in COVID-19
Jeyaraman, M., John, A. A., Koshy, S. K. G., Ranjan, R., Anudeep, T. C., Jain, R., Swati, K., Jha, N. K., Sharma, A., Kesari, K. K., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166014 · Cited by 37
Manzini, B. M., Duarte, A. S. S., Sankaramanivel, S., Ramos, A. L., Latuf-Filho, P., Escanhoela, C. A. F., Kharmandayan, P., Saad, S. T. O., Boin, I. D. F. S. F., & Luzo, Â. C. M. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.04.010 · Cited by 36
Stromal cells in tissue homeostasis: balancing regeneration and fibrosis
Rabelink, T. J., & Little, M. H. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.152 · Cited by 36
Cameron, S. H., Alwakeel, A. J., Goddard, L., Hobbs, C. E., Gowing, E. K., Barnett, E. R., Kohe, S. E., Sizemore, R. J., & Oorschot, D. E. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.03.019 · Cited by 36
Hematopoietic niches, erythropoiesis and anemia of chronic infection
Gomes, A. C., & Gomes, M. S. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.11.007 · Cited by 38
Stem cell transplantation in neurological diseases: improving effectiveness in animal models
Adami, R., Scesa, G., & Bottai, D. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00017 · Cited by 38
Arthritic Microenvironment‐Dictated Fate Decisions for Stem Cells in Cartilage Repair
He, S., Deng, H., Li, P., Hu, J., Yang, Y., Xu, Z., Liu, S., Guo, W., & Guo, Q. (2023) · Advanced Science · doi:10.1002/advs.202207715 · Cited by 36
McGuirk, J. P., Smith, J. E., Divine, C. L., Zuniga, M., & Weiss, M. L. (2015) · Pharmaceuticals · doi:10.3390/ph8020196 · Cited by 35
“As reviewed [124], nestin-positive cells have been shown as prospective markers for native MSC in mouse.”
BackgroundNicorandil protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis
Zhang, F., Cui, J., Lv, B., & Yu, B. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2229 · Cited by 35
“Since MSCs are easily obtained and exhibit impressive paracrine ability, multilineage differentiation potential (27) and the capacity to activate endogenous cardiac progenitor cells (CPCs) (28), they represent one of the most ideal seed cell candidates for tissue regeneration in several clinical…”
GATA2 regulates differentiation of bone marrow-derived mesenchymal stem cells
Kamata, M., Okitsu, Y., Fujiwara, T., Kanehira, M., Nakajima, S., Takahashi, T., Inoue, A., Fukuhara, N., Onishi, Y., Ishizawa, K., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.105692 · Cited by 37
“Efforts to identify the regulatory mechanisms that control the differentiation of BM-MSC into adipocytes/osteoblasts may lead to the development of new clinical applications in the fields of regenerative medicine and tissue engineering and enhance our understanding of hematopoiesis, since BM-MSC are the primary source…”
InfluentialMesenchymal stromal cells in myeloid malignancies
Schroeder, T. A., Geyh, S., Germing, U., & Haas, R. R. (2016) · Blood Research · doi:10.5045/br.2016.51.4.225 · Cited by 38
“Besides their marker profiles, these subsets differ also in parts with regard to their location within the BM cavity and their functional properties [1, 2, 4, 6].”
BackgroundSchiavi, J., Keller, L., Morand, D.-N., de Isla, N., Huck, O., Lutz, J. C., Mainard, D., Schwinté, P., & Benkirane-Jessel, N. (2015) · Nanomedicine · doi:10.2217/nnm.14.228 · Cited by 35
Tracing PRX1+ cells during molar formation and periodontal ligament reconstruction
Gong, X., Zhang, H., Xu, X., Ding, Y., Yang, X., Cheng, Z., Tao, D., Hu, C., Xiang, Y., & Sun, Y. (2022) · International Journal of Oral Science · doi:10.1038/s41368-021-00155-z · Cited by 34
“Thus, the function of PRX1 cells in tissue regeneration and repair could be related to angiogenesis.(20) The development of molars significantly differs from incisors in mouse(21) and is more similar to that of humans.”
BackgroundWu, R., Liu, C., Deng, X., Chen, L., Hao, S., & Ma, L. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14862 · Cited by 33
Chemical-defined medium supporting the expansion of human mesenchymal stem cells
Xu, J., Lian, W., Chen, J., Li, W., Li, L., & Huang, Z. W. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01641-7 · Cited by 33
Grigoryan, A., Zacharaki, D., Balhuizen, A., Côme, C., Garcia, A. G., Gil, D. H., Frank, A.-K., Aaltonen, K. E., Mañas, A., Esfandyari, J., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abm6391 · Cited by 37
Rothdiener, M., Hegemann, M., Uynuk‐Ool, T., Walters, B., Papugy, P., Nguyen, P. K., Claus, V., Seeger, T., Stoeckle, U., Boehme, K. A., et al. (2016) · Scientific Reports · doi:10.1038/srep35840 · Cited by 32
Lerrer, S., Liubomirski, Y., Bott, A., Abnaof, K., Oren, N., Yousaf, A., Körner, C., Meshel, T., Wiemann, S., & Ben‐Baruch, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00479 · Cited by 33
“Among the signals regulating the migration patterns taken by MSCs and their functional diversification are cytokines, which typically are regarded as key regulators of acquired immunity or inflammation (4, 5).”
BackgroundMethodInfluentialMesenchymal Stem Cells in Immune-Mediated Bone Marrow Failure Syndromes
Kastrinaki, M.-C., Pavlaki, K. I., Batsali, A. K., Kouvidi, E., Mavroudi, I., Pontikoglou, C. G., & Papadaki, H. Α. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/265608 · Cited by 33
“Hindawi Publishing Corporation Clinical and Developmental Immunology Volume 2013, Article ID 265608, 10 pages http://dx.doi.org/10.1155/2013/265608”
BackgroundInfluentialThe Hematopoietic Niche in Myeloproliferative Neoplasms
Schmitt-Graeff, A. H., Nitschke, R., & Zeiser, R. (2015) · Mediators of Inflammation · doi:10.1155/2015/347270 · Cited by 32
Guarnerio, J., Coltella, N., Ala, U., Tonon, G., Pandolfi, P. P., & Bernardi, R. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.04.002 · Cited by 30
“Hematopoiesis is a tightly regulated process orchestrated by cell-autonomous and non-cell-autonomous signals emanating from a variety of cell types within specialized bone marrow (BM) microenvironments (Wang and Wagers, 2011; Frenette et al., 2013).”
BackgroundMadden, K. S. (2016) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2016.04.015 · Cited by 31
de Lima, K. A., de Oliveira, G. L. V., Yaochite, J. N. U., Pinheiro, D. G., de Azevedo, J. T. C., Silva, W. A., Covas, D. T., Couri, C. E. B., Simões, B. P., Voltarelli, J. C., et al. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0351-y · Cited by 32
Sensory nerves in the spotlight of the stem cell niche
Picoli, C. C., Costa, A. C., Rocha, B. G. S., da Silva, W. N., Santos, G. S. P., Prazeres, P. H. D. M., Costa, P. A. C., Oropeza, A., da Silva, R. A., Azevedo, V., et al. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0284 · Cited by 30
Du, G., Cheng, X., Zhang, Z., Han, L., Wu, K., Li, Y., & Lin, X. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.759596 · Cited by 31
Perspectives on the Use of Stem Cells for Autism Treatment
Siniscalco, D., Bradstreet, J. J., Sych, N., & Antonucci, N. (2013) · Stem Cells International · doi:10.1155/2013/262438 · Cited by 30
A Genetic Platform to Model Sarcomagenesis from Primary Adult Mesenchymal Stem Cells
Guarnerio, J., Riccardi, L., Taulli, R., Maeda, T., Wang, G., Hobbs, R. M., Song, M. S., Sportoletti, P., Bernardi, R., Bronson, R. T., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1022 · Cited by 30
“osteosarcoma) have been successfully modeled in genetically engineered mice (9-12), current protocols to model undifferentiated sarcomas are generally based on transplantation of human tumor cell lines in immune compromised mice (13), in vitro expanded, and spontaneously transformed heterogeneous mouse primary mesench…”
Schmidt, M., Haagen, J., Noack, R., Siegemund, A., Gabriel, P., & Dörr, W. (2014) · Strahlentherapie und Onkologie · doi:10.1007/s00066-013-0510-3 · Cited by 30
Li, Z., Zhang, S., Cao, L., Li, W., Ye, Y., Shi, Z., Wang, Z., Sun, L., Wang, J., Jia, L., et al. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6428 · Cited by 30
Chen, K. G., Johnson, K. R., McKay, R. D. G., & Robey, P. G. (2017) · Stem Cells · doi:10.1002/stem.2711 · Cited by 29
Regulation of hematopoiesis by activators and inhibitors of Wnt signaling from the niche
Schreck, C., Bock, F., Grziwok, S., Oostendorp, R. A. J., & Istvánffy, R. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12384 · Cited by 31
Trends in Bone Metastasis Modeling
Laranga, R., Duchi, S., Ibrahim, T., Guerrieri, A. N., Donati, D. M., & Lucarelli, E. (2020) · Cancers · doi:10.3390/cancers12082315 · Cited by 31
“The MSCs are multipotent cells that are able to differentiate into the mesenchymal lineage cells, which include osteoblasts, adipocytes, chondrocytes, fibroblasts, and other stromal cells [19,20].”
BackgroundPang, Y., Xiao, H., Zhang, H., Liu, Z., Li, L., Gao, Y., Li, H., Jiang, Z., Tan, H., Lin, J., et al. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.16-0227 · Cited by 28
Disease Progression in Myelodysplastic Syndromes: Do Mesenchymal Cells Pave the Way?
Raaijmakers, M. H. G. P. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.05.010 · Cited by 28
“…cells could contribute to disease pathogenesis in MDS within the framework of our current knowledge of their biology (Morrison and Scadden, 2014, Frenette et al., 2013) and the ‘‘enabling’’ processes underlying neoplastic initiation and progression in other systems (Hanahan and Weinberg, 2011).”
BackgroundA non-cell-autonomous role for Pml in the maintenance of leukemia from the niche
Guarnerio, J., Mendez, L., Asada, N., Menon, A. V., Fung, J., Berry, K., Frenette, P. S., Ito, K., & Pandolfi, P. P. (2017) · Nature Communications · doi:10.1038/s41467-017-02427-x · Cited by 27
Self-citationThe Role of Growth Hormone in Mesenchymal Stem Cell Commitment
Bolamperti, S., GUIDOBONO, F., Rubinacci, A., & Villa, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215264 · Cited by 27
Kidney inflammaging is promoted by CCR2+ macrophages and tissue-derived micro-environmental factors
Lefèvre, L., Iacovoni, J. S., Martini, H., Bellière, J., Maggiorani, D., Dutaur, M., Marsal, D. J., Decaunes, P., Pizzinat, N., Mialet‐Perez, J., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03719-0 · Cited by 27
“Study of other surface markers related to the mesenchymal lineage such as the integrin ß1 (CD29) and the integrin Vα (CD51) [17] by young and aged kMSCs showed no modification with aging (Supp Fig.”
BackgroundThymic Mesenchymal Cells Have a Distinct Transcriptomic Profile
Patenaude, J., & Perreault, C. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502499 · Cited by 26
“Hence, it provides a systems-level appraisal of commonalities and discrepancies between MCs from different organs without being tainted by changes induced by in vitro culture (6).”
BackgroundAggoune, D., Sorel, N., Bonnet, M., Goujon, J., Tarte, K., Hérault, O., Domenech, J., Réa, D., Legros, L., Johnson‐Ansah, H., et al. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.07.007 · Cited by 26
“MSCs are critical self-renewing cells that can differentiate into osteogenic, adipogenic, chondrogenic, and stromal cells of the bone marrow niche [23].”
BackgroundThe impact of gut microbial signals on hematopoietic stem cells and the bone marrow microenvironment
Liu, X., Zhang, H., Shi, G., Zheng, X., Chang, J., Lin, Q., Tian, Z., & Yang, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1338178 · Cited by 30
“MSCs are distributed around blood vessels and contribute to the formation of the hematopoietic niche (24).”
BackgroundChen, K. G., Johnson, K. R., & Robey, P. G. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.09.014 · Cited by 25
“Mouse genetic models have dramatically advanced our understanding of many fundamental developmental processes in both the skeletal and hematological systems, thereby accelerating the processes of translational medicine (Bianco et al., 2013; Frenette et al., 2013; Morrison and Scadden, 2014).”
BackgroundZhao, X., Weinhold, S., Brands, J., Hejazi, M., Degistirici, Ö., Kögler, G., Meisel, R., & Uhrberg, M. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018019059 · Cited by 25
“Mesenchymal stem cells (MSCs) are multipotent mesenchymal stromal cells that are able to differentiate into a variety of mesodermal cell types, such as osteoblasts, chondrocytes, and adipocytes.(11) After birth, MSCs primarily reside in the bone marrow (BM) but are also found at extramedullary sites, such as CB, fat,…”
Background
Metadata
- Authors
- Frenette, P. S., Pinho, S., Lucas, D., & Scheiermann, C.
- Affiliations
- Albert Einstein College of Medicine (US)
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 2013-03-21
- Volume
- 31
- Issue
- 1
- Pages
- 285-316
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W2138953281
- Cited by
- 462
- References
- 235
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 27 · 2023: 27 · 2022: 23 · 2021: 39 · 2020: 35 · 2019: 34 · 2018: 41 · 2017: 42 · 2016: 38 · 2015: 51 · 2014: 54 · 2013: 27
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by
- Locations
- Annual Review of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- National Heart, Lung, and Blood Institute (R01HL116340, R01HL097700, R01HL069438, R01HL097819)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK056638)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Keywords
- mesenchymal stem cells, hematopoietic stem cells, bone marrow microenvironment, stromal progenitor cells, immune function, anti-inflammatory activity, regenerative medicine, stem cell therapy
- MeSH terms
- Animals, Bone Marrow Cells, Humans, Inflammation, Stem Cells, Stromal Cells, Hematopoietic Stem Cell Transplantation, Regenerative Medicine, Mesenchymal Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review